Related Experiment Video
Updated: Jun 26, 2025

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
External Guide Sequence Effectively Suppresses the Gene Expression and Replication of Herpes Simplex Virus 2
Bin Yan1, Yujun Liu1, Yuan-Chuan Chen2
1School of Public Health, University of California, Berkeley, CA 94720, USA.
This study demonstrates that Ribonuclease P (RNase P) with an external guide sequence (EGS) effectively inhibits herpes simplex virus 2 (HSV-2) gene expression and replication by targeting the essential ICP8 protein, reducing viral growth significantly.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- Ribonuclease P (RNase P) complexed with an external guide sequence (EGS) offers a novel nucleic acid-based strategy for gene targeting.
- The RNase P-EGS system leverages intracellular RNase P to cleave specific target mRNAs.
- Herpes Simplex Virus 2 (HSV-2) causes genital herpes and requires essential viral proteins for replication.
Purpose of the Study:
- To investigate the efficacy of the RNase P-EGS approach in blocking gene expression and replication of HSV-2.
- To determine if targeting the HSV-2 ICP8 mRNA using EGS can inhibit viral growth.
- To assess the specificity of the EGS-mediated targeting of HSV-2.
Main Methods:
- Designed and constructed EGSs targeting the mRNA of HSV-2 single-stranded DNA binding protein ICP8.
- Introduced functional and disabled EGSs into HSV-2 infected cells.
- Quantified ICP8 mRNA levels and viral growth in cells with different EGS constructs.
Main Results:
- A functional EGS targeting ICP8 mRNA reduced ICP8 levels by 85% and viral growth by 3000-fold in HSV-2 infected cells.
- Cells with no EGS or a disabled EGS showed no significant reduction in ICP8 expression or viral growth.
- The anti-ICP8 EGS specifically targeted ICP8 without affecting other examined viral immediate-early and early genes.
Conclusions:
- The RNase P-EGS approach demonstrates effective and specific anti-HSV-2 activity.
- EGS RNAs hold significant potential as therapeutic agents for anti-HSV-2 applications.
- This study provides the first direct evidence for the efficacy of RNase P-based gene targeting against HSV-2.
More Related Videos
08:26Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
Published on: August 31, 2017
13:22Detection of the Genome and Transcripts of a Persistent DNA Virus in Neuronal Tissues by Fluorescent In situ Hybridization Combined with Immunostaining
Published on: January 23, 2014
Related Concept Videos
Retroviruses
Retrovirus Life Cycles
Leaky Scanning